Trial · NCT00150579
Efficacy and Safety of SPD465 in Adults With ADHD
NCT00150579, Phase 3, Completed, Shire
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy and Safety of SPD465 in Adults With ADHD. Trials, record NCT00150579. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00150579
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy and Safety of SPD465 in Adults With ADHD
- NCT number
- NCT00150579
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 240 participants
- Lead sponsor
- Shire
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Interventions
- Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate
- First posted
- 2005-09-08
- Last updated
- 2021-06-30
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in the ADHD-rating scale 4th Edition (ADHD-RS-IV) total score to the Endpoint assessment. | Baseline, and the Endpoint (average of weeks 5, 6, 7). | The Endpoint is the average of the values obtained at Weeks 5, 6, and 7. |
| Secondary | Change from Baseline in the Clinical Global Impression of Improvement scale (CGI-I) to the Endpoint assessment. | Baseline, and the Endpoint (average of weeks 5, 6, 7). | The Endpoint is the average of the values obtained at Weeks 5, 6, and 7. |
| Secondary | Change from Baseline in the Time-Sensitive ADHD Symptom Scale (TASS) score to the Endpoint assessment. | Baseline, and the Endpoint (average of weeks 5, 6, 7). | The Endpoint is the average of the values obtained at Weeks 5, 6, and 7. |
| Secondary | Change from Baseline in the Brown Attention Deficit Disorder Scale (BADDS) to the Endpoint assessment | Baseline, and the Endpoint (average of weeks 5, 6, 7). | The Endpoint is the average of the values obtained at Weeks 5, 6, and 7. |
| Secondary | Change in Baseline in the Adult ADHD Impact Module (AIM-A) score to the Endpoint assessment | Baseline, and the Endpoint (average of weeks 5, 6, 7). | The Endpoint is the average of the values obtained at Weeks 5, 6, and 7. |
| Secondary | Change from Baseline in Pittsburgh Sleep Quality Index (PSQI) at Week 1 | Baseline and Week 1. | |
| Secondary | Change from Baseline in Pittsburgh Sleep Quality Index (PSQI) at Week 4 | Baseline and Week 4. | |
| Secondary | Change from Baseline in Pittsburgh Sleep Quality Index (PSQI) at Week 7 | Baseline and Week 7. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00150579
GET https://conductscience.org/api/trials/v1/NCT00150579/registered